Emerging Infectious Diseases (Nov 2021)

Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020

  • Maria Skaalum Petersen,
  • Marnar Fríðheim Kristiansen,
  • Halla Weihe Reinert,
  • Jógvan Páll Fjallsbak,
  • Debes Hammershaimb Christiansen,
  • Shahin Gaini,
  • Bjarni á Steig,
  • Lars Fodgaard Møller,
  • Marin Strøm,
  • Pál Weihe

DOI
https://doi.org/10.3201/eid2711.204948
Journal volume & issue
Vol. 27, no. 11
pp. 2795 – 2801

Abstract

Read online

Close contacts of coronavirus disease (COVID-19) patients are at high risk for severe acute respiratory syndrome 2 (SARS-CoV-2) infection. We assessed the seroprevalence of SARS-CoV-2–specific antibodies among quarantined close contacts of COVID-19 patients in the Faroe Islands. We invited quarantined close contacts of COVID-19 index patients identified during March 3–April 22, 2020, to participate in this study; 584 (81%) contacts consented and underwent serologic testing. Among the 584 participants, 32 (5.5%) were seropositive for total antibody against SARS-CoV-2. Household and young or elderly contacts had higher risk for seropositivity than other contacts. We found a secondary attack rate of 19.2%. Seroprevalence among close contacts was almost 10-fold higher than among the general population of the Faroe Islands. Regularly testing household close contacts of COVID-19 patients might help track the transmission of SARS-CoV-2.

Keywords